Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(83.3%)

Early Phase 1

1(16.7%)

6Total

N/A(5)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02230501Not ApplicableCompleted

Metabolic Activation With Protein-rich Formula Diet

Role: collaborator

NCT03235804Not ApplicableCompleted

The Impact of a Powdered Meal Replacement on Metabolism and Gut Microbiota

Role: collaborator

NCT03565510Not ApplicableCompleted

The Impact of a High-protein Diet on Energy Metabolism in Healthy Men

Role: collaborator

NCT02811276Not ApplicableCompleted

The Impact of a High Protein Diet on Substrate Oxidation and Energy Metabolism

Role: collaborator

NCT01680926Early Phase 1Completed

Metabolic Activation With Almased for Type 2 Diabetes Patients

Role: collaborator

NCT00356785Not ApplicableCompleted

Changes in Body Composition and Metabolic Risk Parameters by Life Style Intervention.

Role: collaborator

All 6 trials loaded